Chemical Component Summary

NameN-{6,6-DIMETHYL-5-[(1-METHYLPIPERIDIN-4-YL)CARBONYL]-1,4,5,6-TETRAHYDROPYRROLO[3,4-C]PYRAZOL-3-YL}-3-METHYLBUTANAMIDE
IdentifiersN-[6,6-dimethyl-5-(1-methylpiperidin-4-yl)carbonyl-1,4-dihydropyrrolo[4,3-d]pyrazol-3-yl]-3-methyl-butanamide
FormulaC19 H31 N5 O2
Molecular Weight361.482
TypeNON-POLYMER
Isomeric SMILESCC(C)CC(=O)Nc1c2c([nH]n1)C(N(C2)C(=O)C3CCN(CC3)C)(C)C
InChIInChI=1S/C19H31N5O2/c1-12(2)10-15(25)20-17-14-11-24(19(3,4)16(14)21-22-17)18(26)13-6-8-23(5)9-7-13/h12-13H,6-11H2,1-5H3,(H2,20,21,22,25)
InChIKeyHUXYBQXJVXOMKX-UHFFFAOYSA-N

Chemical Details

Formal Charge0
Atom Count57
Chiral Atom Count0
Bond Count59
Aromatic Bond Count5

Drug Info: DrugBank

DrugBank IDDB12686 
NamePHA-793887
Groups investigational
DescriptionPHA-793887 has been used in trials studying the treatment of Advanced/Metastatic Solid Tumors.
SynonymsPHA-793887
CategoriesCyclin-Dependent Kinases, antagonists & inhibitors
CAS number718630-59-2

Related Resource References

Resource NameReference
Pharos CHEMBL1230607
PubChem 46191454
ChEMBL CHEMBL1230607
ChEBI CHEBI:91371